Adjuvant Versus Neoadjuvant Therapy in NSCLC

Corey J. Langer, MD, FACP; Karen Kelly, MD; Benjamin P. Levy, MD; and Mark A. Socinski, MD, review emerging data and consider the appropriateness of using adjuvant or neoadjuvant therapy in the perioperative setting of non–small cell lung cancer.